Blackburn, NB and Meikle, PJ and Peralta, JM and Kumar, S and Leandro, AC and Bellinger, MA and Giles, C and Huynh, K and Mahaney, MC and Goring, HHH and VandeBerg, JL and Williams-Blangero, S and Glahn, DC and Duggirala, R and Blangero, J and Michael, LF and Curran, JE, Identifying the lipidomic effects of a rare loss-of-function deletion in ANGPTL3, Circulation. Genomic and Precision Medicine ISSN 2574-8300 (2021) [Refereed Article]
Background: The identification and understanding of therapeutic targets for atherosclerotic cardiovascular disease (ASCVD) is of fundamental importance given its global health and economic burden. Inhibition of angiopoietin-like 3 (ANGPTL3) has demonstrated a cardioprotective effect, showing promise for ASCVD treatment, and is currently the focus of ongoing clinical trials. Here we assessed the genetic basis of variation in ANGPTL3 levels in the San Antonio Family Heart Study.
Methods: We assayed ANGPTL3 protein levels in ~1,000 Mexican Americans from extended pedigrees. By drawing upon existing plasma lipidome profiles and genomic data we conducted analyses to understand the genetic basis to variation in ANGPTL3 protein levels, and accordingly the correlation with the plasma lipidome.
Results: In a variance components framework we identified that variation in ANGPTL3 was significantly heritable (h2=0.33, P=1.31×10-16). To explore the genetic basis of this heritability, we conducted a genome-wide linkage scan and identified significant linkage (LOD = 6.18) to a locus on chromosome 1 at 90 cM, corresponding to the ANGPTL3 gene location. In the genomes of 23 individuals from a single pedigree, we identified a loss of function (LoF) variant, rs398122988 (N121Kfs*2), in ANGPTL3, that was significantly associated with lower ANGPTL3 levels (β=−1.69 SDU, P=3.367×10-13), and accounted for the linkage signal at this locus. Given the known role of ANGPTL3 as an inhibitor of endothelial and lipoprotein lipase we explored the association of ANGPTL3 protein levels and rs398122988 with the plasma lipidome and related phenotypes, identifying novel associations with phosphatidylinositols.
Conclusions: Variation in ANGPTL3 protein levels is heritable and under significant genetic control. Both ANGPTL3 levels and LoF variants in ANGPTL3 have significant associations with the plasma lipidome. These findings further our understanding of ANGPTL3 as a therapeutic target for ASCVD.
|Item Type:||Refereed Article|
|Keywords:||ANGPTL3, lipidomics, linkage, genomics, quantitative genetics, WGS|
|Research Division:||Biological Sciences|
|Research Group:||Bioinformatics and computational biology|
|Research Field:||Statistical and quantitative genetics|
|Objective Group:||Evaluation of health and support services|
|Objective Field:||Evaluation of health outcomes|
|UTAS Author:||Blackburn, NB (Dr Nicholas Blackburn)|
|UTAS Author:||Peralta, JM (Mr Juan Peralta Fernandez)|
|Web of Science® Times Cited:||1|
|Deposited By:||Menzies Institute for Medical Research|
Repository Staff Only: item control page